SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (20313)4/6/1999 7:30:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
*****NEWS*****

Concerning the female SD product:

Vivus will not say more until the following is determined:

1)Dose of alprostadil. Effective dose to be safe and achieve maximum results.
2)Carriers form used--eg ointment, cream, gel, liquid?????
3)How packaged. Individual plastic ampule, tube, jar, etc????
IMO best packaging will be in one dose plastic ampule--seems most logical for dosing consistency. Can be sold eg as a box of 6 ampules just as MUSE is.



To: VLAD who wrote (20313)4/6/1999 7:38:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
This is the site for the Stockholm meeting:

uroweb.org

Apparently it will be updated each day as the presentations are made. If anybody wants to go through each day's schedule and list all ED related lectures go ahead and make a post.

I stand corrected. The meeting begins tonight and we should be able to check daily as the presentations occur.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News